Researchers at Radboud University Medical Center have developed an AI model that can diagnose developmental disorders and syndromes caused by genetic abnormalities by simply scanning children’s faces. This could lead to quick clarity for families on syndromes that would typically take years to diagnose, AD reports.
Bionano Reports Second Quarter 2023 Results And Highlights Recent Business Progress menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Industry News: Measuring heparanase & HS levels in COVID-19 patients
15 Jan 2021
Researchers at Radboud University Medical Center, Netherlands have been utilizing the JM403 Heparan Sulfate Antibody, from AMSBIO, in developing novel assays for measuring heparan sulfate (HS) levels and heparanase activity in COVID-19 patients.
HS is emerging as a key factor in infection by the SARS-CoV-2 virus. Multiple mechanisms underlying the pathogenesis of COVID-19 involve HS, such as cellular infection, inflammation, and vascular leakage due to heparanase-mediated degradation of HS in the endothelial glycocalyx. The JM403 antibody appeared a unique and powerful tool to develop the new assays to measure plasma heparanase and HS levels in patients with COVID-19. A particular advantage of JM403 is that it is not reacting with heparins, which would have been a disturbing factor in our analyses, and which now allowed us to evaluate the effect of treating COVID-19 patients with low molecular weig